BUSINESS BRIEF

The company had developed its first 3D printer in 2016. This is India's first customizable 3D bioprinter. The company is currently in the testing phase for its first product - Bioprinted Human Epidermis. This product has wide application in fields of Cosmetic testing, Pharmaceuticals etc. The founders have long working experience in Biotech Engineering, 3D printing etc, Biomaterial, Electronics etc. The company has following patents: PCT stage - 2 Patents India Granted - 2 Patents Trademarks – Registered Trademarks (3 applications) Grants – $200,000 worth of grants by - Idea2PoC by Government of Karnataka; India Innovation Growth Program by TATA Trusts, Lockheed Martin, DST; Biotechnology Ignition Grant by Department of Biotechnology Convertible Note – Merck Group, Germany Awards – Best Exhibitor (Bengaluru Tech Summit), Best Startup (BioAsia), Autodesk Entrepreneur Impact Program (Autodesk Inc.), IIGP national program awardee (TATA Trusts / DST / Lockheed Martin), Best Upcoming Tissue Engineering Company (Trinity Media) Key Partnerships – Merck Group (Pharma / Life Sciences / Materials R&D / Cosmetics R&D), Dabur Research Foundation (FMCG R&D / External Validations) Company is presently raising Pre Series A Funding of USD 2 Mn for a runway of 18-24 months. Company has hard commitments of USD 500000 out of this.